Cargando…
Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
BACKGROUND: In China, upper tract urothelial carcinoma (UTUC) is less prevalent but more malignant in males. This study investigates the prognostic factors and causes of gender-based differences in Chinese populations. METHODS: Between 1999 and 2011, 687 UTUC patients who underwent surgery were util...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284533/ https://www.ncbi.nlm.nih.gov/pubmed/30584358 http://dx.doi.org/10.2147/CMAR.S178554 |
_version_ | 1783379349928411136 |
---|---|
author | Xiong, Gengyan Yao, Lin Hong, Peng Yang, Li Ci, Weimin Liu, Libo He, Qun Gong, Kan Li, Xuesong Zhou, Liqun |
author_facet | Xiong, Gengyan Yao, Lin Hong, Peng Yang, Li Ci, Weimin Liu, Libo He, Qun Gong, Kan Li, Xuesong Zhou, Liqun |
author_sort | Xiong, Gengyan |
collection | PubMed |
description | BACKGROUND: In China, upper tract urothelial carcinoma (UTUC) is less prevalent but more malignant in males. This study investigates the prognostic factors and causes of gender-based differences in Chinese populations. METHODS: Between 1999 and 2011, 687 UTUC patients who underwent surgery were utilized for this study. We evaluated the differences in oncological characteristics, epigenetic biomarkers, cancer-specific survival (CSS), bladder recurrence (BR) rate, and contralateral upper tract recurrence (CUTR) rate. Smoking history, benzene exposure history, and the history of using aristolochic acid (AA) containing herbs were analyzed in detail. RESULTS: Compared with male patients, female patients showed poorer renal function, lower proportions of tumor stage III/IV, and smaller tumor diameters. The CSS in male patients was lower than that in female patients. Significant gender-related differences were observed concerning various prognostic factors. In female patients, poorer survival rates were attributed to the primary tumor location in the ureter, large diameter primary tumors, severe chronic kidney disease, papillary tumor architecture, high tumor stages, positive N status, and methylated ABCC6 promoters. In male patients, older age, ipsilateral hydronephrosis, large tumor diameters, sessile tumor architecture, high tumor stages, and methylated TMEFF2 promoters were associated with higher cancer-specific mortality. AA might be the main cause of these gender-based differences. The AA-induced UTUC patients presented smaller tumor diameters, lower tumor stages, fewer positive N statuses, more multifocal tumors, lower methylation indices, and poorer renal function. Although AA-induced UTUC patients exhibited better survival rates, BR and CUTR rates were significantly worse. CONCLUSION: In China, there exist significant AA-induced differences between male and female UTUC patients. The bladders and contralateral upper urinary tracts of AA-induced UTUC patients should be carefully monitored after surgery. |
format | Online Article Text |
id | pubmed-6284533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62845332018-12-24 Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients Xiong, Gengyan Yao, Lin Hong, Peng Yang, Li Ci, Weimin Liu, Libo He, Qun Gong, Kan Li, Xuesong Zhou, Liqun Cancer Manag Res Original Research BACKGROUND: In China, upper tract urothelial carcinoma (UTUC) is less prevalent but more malignant in males. This study investigates the prognostic factors and causes of gender-based differences in Chinese populations. METHODS: Between 1999 and 2011, 687 UTUC patients who underwent surgery were utilized for this study. We evaluated the differences in oncological characteristics, epigenetic biomarkers, cancer-specific survival (CSS), bladder recurrence (BR) rate, and contralateral upper tract recurrence (CUTR) rate. Smoking history, benzene exposure history, and the history of using aristolochic acid (AA) containing herbs were analyzed in detail. RESULTS: Compared with male patients, female patients showed poorer renal function, lower proportions of tumor stage III/IV, and smaller tumor diameters. The CSS in male patients was lower than that in female patients. Significant gender-related differences were observed concerning various prognostic factors. In female patients, poorer survival rates were attributed to the primary tumor location in the ureter, large diameter primary tumors, severe chronic kidney disease, papillary tumor architecture, high tumor stages, positive N status, and methylated ABCC6 promoters. In male patients, older age, ipsilateral hydronephrosis, large tumor diameters, sessile tumor architecture, high tumor stages, and methylated TMEFF2 promoters were associated with higher cancer-specific mortality. AA might be the main cause of these gender-based differences. The AA-induced UTUC patients presented smaller tumor diameters, lower tumor stages, fewer positive N statuses, more multifocal tumors, lower methylation indices, and poorer renal function. Although AA-induced UTUC patients exhibited better survival rates, BR and CUTR rates were significantly worse. CONCLUSION: In China, there exist significant AA-induced differences between male and female UTUC patients. The bladders and contralateral upper urinary tracts of AA-induced UTUC patients should be carefully monitored after surgery. Dove Medical Press 2018-12-04 /pmc/articles/PMC6284533/ /pubmed/30584358 http://dx.doi.org/10.2147/CMAR.S178554 Text en © 2018 Xiong et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Xiong, Gengyan Yao, Lin Hong, Peng Yang, Li Ci, Weimin Liu, Libo He, Qun Gong, Kan Li, Xuesong Zhou, Liqun Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients |
title | Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients |
title_full | Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients |
title_fullStr | Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients |
title_full_unstemmed | Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients |
title_short | Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients |
title_sort | aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284533/ https://www.ncbi.nlm.nih.gov/pubmed/30584358 http://dx.doi.org/10.2147/CMAR.S178554 |
work_keys_str_mv | AT xionggengyan aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients AT yaolin aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients AT hongpeng aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients AT yangli aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients AT ciweimin aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients AT liulibo aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients AT hequn aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients AT gongkan aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients AT lixuesong aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients AT zhouliqun aristolochicacidcontainingherbsinducegenderrelatedoncologicaldifferencesinuppertracturothelialcarcinomapatients |